Nemec P, Bedanova H, Necas J, Meluzin J, Stetka F, Pokorny P, Utrata P, Cerny J
Centrum of Cardiovascular and Transplant Surgery, Brno.
Bratisl Lek Listy. 2001;102(1):15-21.
The results of a merely pharmacological therapy in patients with advanced left ventricular dysfunction are unsatisfactory. Coronary artery bypass grafting is frequently the only therapeutic option, but ventricular dysfunction is generally considered to be a risk factor.
To find out the frequency of coronary artery bypass grafting and its outcome in patients with a ejection fraction of 30% or less who were operated on at a single institution.
Between January 1st, 1996 and October 30th, 1999, 90 patients (4.6% of all patients operated on due to of coronary artery disease) with EF of 30% or less underwent coronary artery bypass grafting. This group consisted of 12 women and 78 men at an average age of 60.2 +/- 9.4 years (range, 33 to 78 years); 75.6% patients were in functional class III or IV and 80.0% had three-vessel disease. On the average, 2.5 grafts per patient were implanted, the left internal mammary artery was used in 24.4% patients, and 10.0% of patients had cardiac surgery without cardiopulmonary bypass.
Hospital mortality was 10%. The main cause of death was cardiac or multiorgan failure. Low cardiac output syndrome and supraventricular dysrrhythmias were the most common postoperative complications. Advanced age and low cardiac output syndrome were found to be risk factors of early mortality. Five other patients died during the follow-up (4 to 48 months). One- and three-year survival rate were 83.1% and 81.9%, respectively. Ejection fraction improved during the follow-up from 27.5% to 33.7%. The improvement was more pronounced in patients in whom preoperative end-diastolic diameter of the left ventricle was below 70 mm, and in patients with two and more hibernating segments on dobutamine stress echo.
Successful results of surgical revascularization in patients with severe impairment of left ventricular function can be achieved by careful selection of patients (the presence of viable myocardium is necessary) and management. Early mortality and morbidity was higher than in patients with normal ventricular function. Age and low cardiac output syndrome were revealed as risk factors of early mortality. Long-term prognosis for hospital survivals was satisfactory. (Tab. 5, Fig. 1, Ref. 13.)
对于晚期左心室功能不全患者,单纯药物治疗的效果并不理想。冠状动脉旁路移植术常常是唯一的治疗选择,但心室功能不全通常被视为一个危险因素。
了解在一家机构接受手术的射血分数为30%或更低的患者中冠状动脉旁路移植术的频率及其结果。
1996年1月1日至1999年10月30日期间,90例射血分数为30%或更低的患者(占所有因冠状动脉疾病接受手术患者的4.6%)接受了冠状动脉旁路移植术。该组包括12名女性和78名男性,平均年龄为60.2±9.4岁(范围为33至78岁);75.6%的患者心功能分级为III或IV级,80.0%的患者患有三支血管病变。平均每位患者植入2.5根移植血管,24.4%的患者使用了左乳内动脉,10.0%的患者接受了非体外循环心脏手术。
医院死亡率为10%。主要死亡原因是心脏或多器官衰竭。低心排血量综合征和室上性心律失常是最常见的术后并发症。高龄和低心排血量综合征被发现是早期死亡的危险因素。另外5例患者在随访期间死亡(4至48个月)。1年和3年生存率分别为83.1%和81.9%。随访期间射血分数从27.5%提高到33.7%。在术前左心室舒张末期直径低于70 mm的患者以及多巴酚丁胺负荷超声心动图显示有两个或更多冬眠节段的患者中,改善更为明显。
通过仔细选择患者(必须存在存活心肌)并进行管理,可以在左心室功能严重受损的患者中取得手术血运重建的成功结果。早期死亡率和发病率高于心室功能正常的患者。年龄和低心排血量综合征被揭示为早期死亡的危险因素。医院存活患者的长期预后良好。(表5,图1,参考文献13。)